// App-Quantinova.ai

i055 : Tuberculosis and opportunistic infections in the age of biologics

Researchers

Presenter

  • Gerry Davies

Principal Investigators

  • N/A

Medical Centers

  • Clinical Infection Microbiology and Immunology, University of Liverpool, Liverpool, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Tuberculosis

Biomarkers

  • Interferon-gamma

Drug/Treatment

  • Interferon Gamma

  • Tuberculin

  • Isoniazid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved